Opportunity Information: Apply for RFA NR 12 005
Apply for RFA NR 12 005
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Palliative Care and End of Life in People Living with HIV/AIDS (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.361 Nursing Research.
- This funding opportunity was created on Dec 2, 2011 and posted on Dec 2, 2011.
- Applicants must submit their applications by Mar 22, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,100,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Special district governments Native American tribal governments (Federally recognized) County governments For profit organizations other than small businesses Independent school districts Small businesses Others (see text field entitled Additional Information on Eligibility for clarification) Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are noteligible to apply. Non domestic (non U.S.) components of U.S. Organizations are noteligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are notallowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Palliative Care and End of Life in People Living with HIV/AIDS (R21)" (Funding Opportunity Number RFA-NR-12-005), was issued by the National Institutes of Health through the National Institute of Nursing Research (NINR). It invites exploratory and developmental research that looks closely at the real-world palliative care (PC) and end-of-life (EOL) needs of people living with HIV/AIDS (PLWHA). The core idea behind the announcement is that highly active antiretroviral therapy (HAART) has significantly extended life expectancy, which means more people are living longer with HIV and ultimately reaching later stages of illness where high-quality symptom management, supportive care, and end-of-life planning become essential. NINR is specifically emphasizing that these needs are especially urgent in communities where HIV prevalence is highest and where HIV-related mortality remains disproportionately elevated, pointing applicants toward questions of equity, access, and culturally responsive care.
The opportunity uses the NIH R21 mechanism, which is typically meant for early-stage, innovative, or pilot-style studies that can generate foundational data, refine interventions, or establish feasibility for larger future projects. The funding instrument is a grant, categorized under education and health, and tied to CFDA number 93.361 (Nursing Research). The total estimated funding associated with the announcement is $2.1 million, and the award ceiling is listed as $200,000. There is no cost-sharing or matching requirement, meaning applicants are not required to contribute non-federal funds to be eligible.
In terms of who can apply, eligibility is broad and spans many types of domestic organizations. Eligible applicants include public and private institutions of higher education (including state-controlled institutions), nonprofits with and without 501(c)(3) status, state and local governments (including counties, cities or townships, special district governments, and independent school districts), Native American tribal governments and tribal organizations (both federally recognized and other than federally recognized), public housing authorities/Indian housing authorities, regional organizations, and for-profit organizations (with the note that the category explicitly includes entities other than small businesses as well as small businesses). The announcement also highlights additional eligible categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based or community-based organizations, U.S. territories or possessions, and eligible federal agencies. At the same time, it clearly excludes non-U.S. entities: foreign institutions are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.
Key dates show that the opportunity was posted and created on December 2, 2011, with an original and current closing date of March 22, 2012, and an archive date of April 22, 2012. The full announcement was made available through an NIH link provided in the notice. For technical issues accessing or linking to the announcement, the contact point listed is the NIH Office of Extramural Research (OER) Webmaster via FBOWebmaster@OD.NIH.GOV.
Overall, this R21 focuses on improving the evidence base around how palliative and end-of-life care should be delivered for people living with HIV/AIDS in the modern treatment era, with an eye toward the changing clinical trajectory created by HAART and the persistent disparities faced by the populations most affected by HIV.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The funding opportunity is titled "Palliative Care and End of Life in People Living with HIV/AIDS (R21)".
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is RFA-NR-12-005.
Which agency is offering this opportunity?
This opportunity was issued by the National Institutes of Health (NIH) through the National Institute of Nursing Research (NINR).
What type of research is this funding intended to support?
It supports exploratory and developmental research focused on the real-world palliative care (PC) and end-of-life (EOL) needs of people living with HIV/AIDS (PLWHA).
What is the main purpose or rationale behind the announcement?
The announcement emphasizes that highly active antiretroviral therapy (HAART) has extended life expectancy for people living with HIV, meaning more individuals are living longer and eventually reaching later stages of illness where symptom management, supportive care, and end-of-life planning become increasingly important.
Does the opportunity highlight any priority populations or equity concerns?
Yes. NINR stresses that palliative and end-of-life needs are especially urgent in communities where HIV prevalence is highest and where HIV-related mortality remains disproportionately elevated. This points applicants toward questions of equity, access, and culturally responsive care.
What funding mechanism does this opportunity use?
The opportunity uses the NIH R21 mechanism.
What does the R21 mechanism typically support?
R21 awards are typically intended for early-stage, innovative, or pilot-style studies that can generate foundational data, refine interventions, or establish feasibility for larger future projects.
What is the funding instrument for this opportunity?
The funding instrument is a grant.
How is this opportunity categorized?
It is categorized under education and health.
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.361 (Nursing Research).
How much total funding is estimated for this announcement?
The total estimated funding associated with the announcement is $2.1 million.
What is the award ceiling?
The award ceiling is listed as $200,000.
Is cost sharing or matching required?
No. The opportunity states there is no cost-sharing or matching requirement, meaning applicants are not required to contribute non-federal funds to be eligible.
Who is eligible to apply?
Eligibility is broad and includes many types of domestic organizations, including:
- Public and private institutions of higher education (including state-controlled institutions)
- Nonprofits with and without 501(c)(3) status
- State and local governments (including counties, cities/townships, special districts, and independent school districts)
- Native American tribal governments and tribal organizations (federally recognized and other than federally recognized)
- Public housing authorities/Indian housing authorities
- Regional organizations
- For-profit organizations (including small businesses and entities other than small businesses)
Are specific institution types explicitly encouraged or included?
Yes. The announcement explicitly includes categories such as:
- Historically Black Colleges and Universities (HBCUs)
- Hispanic-Serving Institutions
- Tribally Controlled Colleges and Universities (TCCUs)
- Alaska Native and Native Hawaiian Serving Institutions
- Faith-based or community-based organizations
- U.S. territories or possessions
- Eligible federal agencies
Are foreign organizations eligible to apply?
No. The opportunity explicitly states that foreign institutions are not eligible to apply.
Are non-domestic components of U.S. organizations allowed?
No. Non-domestic components of U.S. organizations are not eligible under this opportunity.
Are foreign components (as defined by NIH policy) allowed?
No. The opportunity states that foreign components are not allowed as defined by NIH policy.
When was this opportunity posted?
The opportunity was posted (and created) on December 2, 2011.
What was the application closing date?
The original and current closing date listed is March 22, 2012.
When was the opportunity archived?
The archive date is listed as April 22, 2012.
Where can applicants find the full announcement?
The full announcement was made available through an NIH link provided in the notice.
Who should be contacted for technical issues accessing or linking to the announcement?
For technical issues accessing or linking to the announcement, the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
What is the overall focus of the funded work?
The overall focus is to improve the evidence base for how palliative and end-of-life care should be delivered for people living with HIV/AIDS in the modern treatment era, taking into account both the changing clinical trajectory created by HAART and persistent disparities in populations most affected by HIV.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Long Term Resource Monitoring Program FY 2012
Previous opportunity: Palliative Care and End of Life in People Living with HIV/AIDS(R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA NR 12 005
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA NR 12 005) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54) Apply for PAR 12 055 Funding Number: PAR 12 055 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition The Medical Education Partnership Initiative Linked Awards (MEPI) (R25) Apply for RFA TW 11 004 Funding Number: RFA TW 11 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| The Chernobyl Tissue Bank Coordinating Center (Limited Competition U24) Apply for RFA CA 12 501 Funding Number: RFA CA 12 501 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Apply for PAR 12 050 Funding Number: PAR 12 050 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08) Apply for PAR 12 051 Funding Number: PAR 12 051 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Mentored Patient Oriented Research Career Development Award to Promote Diversity (K23) Apply for PAR 12 052 Funding Number: PAR 12 052 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Maternal Nutrition and Pre pregnancy Obesity Effects on Mothers, Infants and Children (R01) Apply for PA 12 061 Funding Number: PA 12 061 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The NCI Transition Career Development Award to Promote Diversity (K22) Apply for PAR 12 062 Funding Number: PAR 12 062 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Early Stage Innovative Technology Development for Cancer Research (R21) Apply for RFA CA 12 002 Funding Number: RFA CA 12 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Validation and Advanced Development of Emerging Technologies for Cancer Research (R33) Apply for RFA CA 12 003 Funding Number: RFA CA 12 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Innovative and Early Stage Development of Emerging Technologies in Biospecimen Science (R21) Apply for RFA CA 12 004 Funding Number: RFA CA 12 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Validation and Advanced Development of Emerging Technologies in Biospecimen Science (R33) Apply for RFA CA 12 005 Funding Number: RFA CA 12 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| NCI Established Investigator Award in Cancer Prevention and Control (K05) Apply for PAR 12 065 Funding Number: PAR 12 065 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Imaging Science Track Award for Research Transition (I/START) R03 Apply for PAR 12 066 Funding Number: PAR 12 066 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Human Health and Heredity in Africa (H3Africa) Research Grants (U01) Apply for RFA RM 12 004 Funding Number: RFA RM 12 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Small Grants for Behavioral Research in Cancer Control (R03) Apply for PAR 12 035 Funding Number: PAR 12 035 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07) Apply for PAR 12 067 Funding Number: PAR 12 067 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Fogarty HIV Research Training Program for Low and Middle Income Country Institutions (D43) Apply for PAR 12 068 Funding Number: PAR 12 068 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pediatric Phase 1/Pilot Consortium (Limited Competition UM1) Apply for RFA CA 12 502 Funding Number: RFA CA 12 502 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Biomechanisms of Peripheral Nerve Damage by Anti Cancer Therapy (R21) Apply for PA 12 083 Funding Number: PA 12 083 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA NR 12 005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.